Annual report pursuant to Section 13 and 15(d)

Organization, Basis of Presentation and Consolidation, and Significant Accounting Policies - Additional Information (Details)

v3.22.1
Organization, Basis of Presentation and Consolidation, and Significant Accounting Policies - Additional Information (Details)
 12 Months Ended
Nov. 30, 2021
shares
Nov. 03, 2021
USD ($)
Nov. 02, 2021
USD ($)
$ / shares
shares
Oct. 18, 2021
Dec. 31, 2021
USD ($)
$ / shares
Dec. 31, 2020
USD ($)
Dec. 31, 2019
USD ($)
Subsidiary, Sale of Stock [Line Items]              
Reverse stock split ratio       0.06262000      
Common stock, par value (in usd per share) | $ / shares         $ 0.001    
Payment of initial public offering issuance costs         $ 5,543,000 $ 0 $ 0
Recognition of liability under tax receivable agreement         $ 210,639,000 0 $ 0
Exercises (in shares) | shares 2,424            
Tax receivable agreements, percentage of benefits payable to shareholders         0.85    
Restricted cash held in escrow         $ 37,352,000 26,709,000  
Restricted cash and cash equivalents         3,900,000 3,900,000  
Deferred offering costs         $ 5,500,000    
Capitalized contract cost, amortization period         7 years    
CARES retention credits         $ 3,900,000    
Former Investor              
Subsidiary, Sale of Stock [Line Items]              
Restricted cash held in escrow         $ 1,100,000 1,100,000  
Minimum              
Subsidiary, Sale of Stock [Line Items]              
Lessee, operating lease, term of contract         2 years    
Maximum              
Subsidiary, Sale of Stock [Line Items]              
Lessee, operating lease, term of contract         15 years    
International Operations              
Subsidiary, Sale of Stock [Line Items]              
Restricted cash and cash equivalents         $ 200,000 $ 0  
Second Lien Term Loan Facility | Line of Credit              
Subsidiary, Sale of Stock [Line Items]              
Repayments of debt   $ 215,000,000          
Write off of unamortized deferred financing fees and issuance discount         $ 5,200,000    
IPO              
Subsidiary, Sale of Stock [Line Items]              
Sale of stock, number of shares issued (in shares) | shares     22,222,222        
Sale of stock, price (in usd per share) | $ / shares     $ 19.00        
Sale of stock, consideration received     $ 393,500,000        
Payment of initial public offering issuance costs     23,200,000        
Recognition of liability under tax receivable agreement     $ 5,500,000